Welcome to the international HTA database

Showing [23371 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	Blue Cross Blue Shield Association (BCBS)	Fractional flow reserve and coronary artery revascularization
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Quality assessment of the Canadian attention deficit hyperactivity disorder resource alliance ADHD practice guidelines for children, adolescents and adults with ADHD
2011	HAYES, Inc.	Continuous passive motion for the treatment of joint contractures of the extremities
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Abraxane for malignant melanoma – first line
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Everolimus (Afinitor) for the treatment of renal cell carcinoma]
2011	Blue Cross Blue Shield Association (BCBS)	Computed tomographic coronary angiography in the evaluation of patients with acute chest pain
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines
2011	HAYES, Inc.	Diaphragmatic/phrenic nerve stimulation
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy
2011	Andalusian Health Technology Assessment Area (AETSA)	[Prenatal screening for aneuploidy using free fetal DNA in maternal blood. Systematic review of the literature.]
2011	NIHR Health Technology Assessment programme	Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
2011	Blue Cross Blue Shield Association (BCBS)	Special report: maintenance therapy in advanced non-small-cell lung cancer
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Safety of air vents in psychiatric units in a hospital setting: a review of the clinical evidence and guidelines
2011	HAYES, Inc.	Endoscopic ultrasound (EUS) for diagnosis of pancreatic tumors
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) with octreotide (Sandostatin) for high risk carcinoid tumours – first or second line
2011	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of active immunotherapy in HIV-infected adults. Therapeutic vaccines against HIV.]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Lapatinib (Tyverb) for the treatment of metastatic breast cancer]
2011	Blue Cross Blue Shield Association (BCBS)	Transcranial magnetic stimulation for depression
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	MALDI-TOF mass spectrometry for bacterial species identification: a review of diagnostic accuracy and clinical and cost-effectiveness
2011	HAYES, Inc.	Endoscopic ultrasound (EUS) for locoregional staging of pancreatic tumors
2011	Andalusian Health Technology Assessment Area (AETSA)	[Use of QALYs in different clinical situations]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ventilation/perfusion scintigraphy (using Technegas) versus computed tomography pulmonary angiography for the diagnosis of pulmonary embolism in hospitalized patients: a review of the clinical and cost-effectiveness
2011	HAYES, Inc.	Endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNA) for diagnosis of pancreatic cancer
2011	Andalusian Health Technology Assessment Area (AETSA)	[Impella Recover® 2.5 ventricular assist device]
2011	Penn Medicine Center for Evidence-based Practice (CEP)	Celecoxib for pain control in joint arthroplasty
2011	HAYES, Inc.	High-frequency chest wall compression for diseases other than cystic fibrosis
2011	Andalusian Health Technology Assessment Area (AETSA)	[Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011	Medical Advisory Secretariat (MAS)	Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis
2011	HAYES, Inc.	Intranasal trivalent live attenuated influenza vaccine
2011	Health Information and Quality Authority (HIQA)	A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
2011	Penn Medicine Center for Evidence-based Practice (CEP)	Argon plasma coagulation for surgical procedures
2011	National Institute for Health and Care Excellence (NICE)	Golimumab for the treatment of psoriatic arthritis. NICE technology appraisal guidance 220
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Tolvaptan (Samsca) for the treatment of hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion]
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Computerised cognitive behavioural therapy for adults with depression
2011	HAYES, Inc.	Mechanical stretching devices for the treatment of joint contractures of the extremities
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Cetuximab (Erbitux) in combination with oxaliplatin, leucovorin and fluorouracil for colorectal cancer - adjuvant
2011	HAYES, Inc.	testing
2011	National Institute for Health and Care Excellence (NICE)	Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia. NICE technology appraisal guidance 218
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Transnasal oesophagoscopy (TNE)
2011	HAYES, Inc.	Nerve blocks for the treatment of chronic nonmalignant pain
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Brivanib for hepatocellular carcinoma – second line
2011	HAYES, Inc.	title
2011	National Institute for Health and Care Excellence (NICE)	Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer. NICE technology appraisal guidance 214
2011	HAYES, Inc.	Neuronavigation for intracranial biopsy and intracranial surgery
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Cetuximab (Erbitux) in combination with capecitabine and cisplatin for advanced or metastatic gastric cancer – first line
2011	National Institute for Health and Care Excellence (NICE)	Bendamustine for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 216
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Enzymatic replacement treatment for type I gaucher's disease patients]
2011	HAYES, Inc.	Positron Emission Tomography (PET) and combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and initial staging of ovarian cancer
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2011	National Institute for Health and Care Excellence (NICE)	Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years. NICE technology appraisal guidance 213
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Literature review of organisational and patient aspects in HTA]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical Practice Guideline on the care for people with alzheimer's disease and dementia]
2011	Medical Advisory Secretariat (MAS)	Continuous glucose monitoring for patients with diabetes
2011	HAYES, Inc.	Progesterone for the prevention of preterm birth
2011	NIHR Horizon Scanning Centre (NIHR HSC)	EC145 for folate receptor positive ovarian cancer
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of urea breath test for helicobacter pylori detection]
2011	HAYES, Inc.	Recombinant human bone morphogenetic protein for use in spinal fusion
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2011	Health Information and Quality Authority (HIQA)	Health technology assessment of robot-assisted surgery in selected surgical procedures
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nucleoplasty for patients with discogenic back pain]
2011	HAYES, Inc.	Recombinant human bone morphogenetic protein for use in tibia repair
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of the bilateral cochlear implant in children]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients with stroke or brain trauma]
2011	HAYES, Inc.	Robotically assisted stereotactic radiosurgery for intracranial indications
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Ipilimumab (Yervoy) for prostate cancer – second line
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dabigatran for the prevention of ischemic stroke in patients with acute or chronic atrial fibrillation]
2011	Institut national d'excellence en sante et en services sociaux (INESSS)	[Indications for positron emission tomography (pet): a brief update]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vagus nerve stimulation for refractory epilepsy]
2011	HAYES, Inc.	Robotically assisted stereotactic radiosurgery for thoracic and abdominal indications
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib with gemcitabine for advanced or metastatic pancreatic cancer
2011	Institute of Health Economics (IHE)	Fecal transplantation for the treatment of clostridium difficile-associated disease or ulcerative colitis
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of urea breath test for helicobacter pylori detection]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sacral nerve stimulation for the treatment of voiding dysfunction]
2011	HAYES, Inc.	Robotically assisted stereotactic radiosurgery (SRS) for spinal and extracranial head and neck indications
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Paclitaxel (Paclical) for epithelial ovarian cancer, fallopian tube cancer or peritoneal cancer – second or third line
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pascal laser use in the treatment of retinal pathology]
2011	Medical Services Advisory Committee (MSAC)	Use of artificial disc replacement in patients with cervical degenerative disc disease
2011	Institute for Clinical Evaluative Sciences (ICES)	Geographic access to primary care and hospital services for rural and northern communities: Report to the Ontario Ministry of Health and Long-Term Care.
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients who underwent cardiac arrest resuscitation]
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Dalcetrapib for the prevention of cardiovascular events
2011	Medical Services Advisory Committee (MSAC)	Assessment of application for joint injections
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Botulinum toxin use in adults and children with urinary tract function disorders]
2011	HAYES, Inc.	HLA-B*27 testing for ankylosing spondylitis
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Edoxaban tosylate for prevention of stroke and systemic embolic events in non-valvular atrial fibrillation
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Carotid echo doppler for plaque area measurement in cardiovascular risk stratification]
2011	Medical Services Advisory Committee (MSAC)	Review of interim funded service: Hyperbaric Oxygen Therapy (HBOT) for the treatment of chronic non-diabetic wounds and non-neurological soft tissue radiation injuries
2011	Institute for Clinical Evaluative Sciences (ICES)	Economic evaluation of percutaneous coronary intervention in stable coronary artery disease: studies in utilities, costs and decision modelling
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pipeline embolization device]
2011	HAYES, Inc.	KIT and PDGFRA testing for diagnosis of gastrointestinal stromal tumors (GISTs)
2011	NIHR Horizon Scanning Centre (NIHR HSC)	HHLivC (Human Heterologous Liver Cells) for urea cycle disorders
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of COL4A1 gene sequencing]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Benefit assessment of HPV testing in primary screening for cervical cancer]
2011	Basque Office for Health Technology Assessment (OSTEBA)	[Analysis and development of preventive activities in primary care. Review of the preferential offer and its support software (PAP)]
2011	HAYES, Inc.	KIT and PDGFRA testing for prognosis of gastrointestinal stromal tumors (GISTs)
2011	NIHR Horizon Scanning Centre (NIHR HSC)	ThromboLUX™ for determining platelet quality
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	HIFU for the treatment of prostate cancer
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of a specific intra-necrotic interventional technique for the diabetic Foot]
2011	Medical Services Advisory Committee (MSAC)	Review of MBS Items for specific ophthalmology services under the MBS Quality Framework Stage 1